Comparison of Pharma Outsourcing between China and India: Industry Research Report

Comparison of Pharma Outsourcing between China and India

Published Date: July 2009

Published By: JZMed, Inc.

Page Count: 152

Order Code: R3594-7

Questions About This Report

E-mail a Colleague

Printable Page

Fax Your Order

Description

Table of Contents

Similar
Products

Scope of the Report

Advantages and disadvantages of China and India in pharma outsourcing:

About Author

Executive Summary

China and India: The two most favored places for pharma outsourcing
Head-to-head comparison of two countries

Strengths and shortcomings of China and India in pharma outsourcing:

Head-to-head comparison of top 50 best service providers of each country

Which country best fits your outsourcing investment? – A series of case studies

Summary

Chapter 1. China and India: The Two Most Favored Places for Pharma Outsourcing
1.1 Introduction

1.1.1 World pharmaceutical industry is currently experiencing downturn

and outsourcing is one of the effective solutions to quickly turn it around

1.1.2 Center of pharma outsourcing industry has shifted to the East

1.1.3 Emerging of China and India as favored places for outsourcing

1. Emerging of Chinese pharma outsourcing industry

2. Emerging of Indian pharma outsourcing industry

1.2 Fast development of pharma outsourcing industries in China and India

1.2.1 Development patterns of pharma outsourcing industry in China and India

1. Development pattern of Chinese pharma outsourcing industry

2. Development pattern of Indian pharma outsourcing industry

1.2.2 Market development of pharma outsourcing in China and India

1. Market development of pharma outsourcing in China

a. Market development history and current market sizes of Chinese pharma outsourcing

b. Current market sizes of each service sector

2. Market development of pharma outsourcing in India

a. Market development history and current market sizes of Indian pharma outsourcing

b. Current market sizes of each service sector

3. How to compare with global pharma outsourcing markets

a. Current total market sizes of global pharma outsourcing industry

b. Current global market sizes of each service sector and their distributions

1.3 Growing importance of China and India to world pharma industry

1.4 Summary of current development trend of global pharma outsourcing industry

Chapter 2. Advantages and Disadvantages of China and India in Pharma

Summary

Outsourcing: Head-to-Head Comparison of Two Countries
2.1 Introduction

2.2 General comparisons between China and India

2.2.1 Comparison of higher education systems between China and India

2.2.2 Comparison of workforce structure in pharmaceutical industry

2.2.3 Comparison of labor and raw material costs in pharmaceutical industry

2.2.4 Comparison of general industry infrastructure

2.2.5 Comparison of business philosophy

2.3 Comparison of intellectual property (IP) protection environment between

China and India

2.4 Comparison of pharmaceutical industries between China and India

2.4.1 Comparison of development history of pharmaceutical industries in China and India

2.4.2 Comparison of pharmaceutical markets between China and India

1. Chinese pharmaceutical market sizes

2. Indian pharmaceutical market sizes

2.4.3 Comparison of general capabilities of pharmaceutical industry between China and India

1. Chinese pharmaceutical industry

2. Indian pharmaceutical industry

2.4.4 Comparison of drug R&D capabilities between China and India

2.5 Comparison of biotech industries between China and India

2.5.1 Chinese biotech industry

2.5.2 Indian biotech industry

2.6 Conclusions

Chapter 3. Strengths and Shortcomings of China and India in Pharma

Outsourcing: Head-to-Head Comparison of Top 50 Best Service

Providers of Each Country

Summary

3.1 Introduction

3.2 Comparison of overall service capabilities of pharma outsourcing in

China and India

3.2.1 Overall service capability of Chinese pharma outsourcing industry

3.2.2 Overall service capability of Indian pharma outsourcing industry

3.3 Head-to-head comparison of top 50 best outsourcing service providers in

each country

3.3.1 Selection of top 50 best service providers in each country

3.3.2 Criteria for selection of top 50 best service providers in each country

1. Selection criteria

2. Classification and definition of CRO/CMO service capabilities

3. Classification of players and their ratings

4. Selection

3.3.3 Head-to-head comparisons of selected top 50 best players in each country

1. Comparison of service provider distributions

2. Comparison of professional service providers in each service sector

3. Comparison of service capabilities between Chinese companies and Indian companies

4. Comparison of current states of internal drug R&D programs and capabilities between Chinese companies and Indian companies

5. Comparison of service capabilities in biopharmaceutical manufacturing

6. Comparison of global presences of Chinese companies and Indian companies

7. Summary of head-to-head comparisons

3.4 Case studies: Head-to-head comparisons of typical Chinese companies with typical Indian companies

3.4.1 Comparison between a Chinese CRO and an Indian CRO

3.4.2 Comparison between a major Chinese pharma company and a major Indian pharma company

3.4.3 Comparison between a major Chinese biotech company and a major Indian biotech company

3.5 How financial crisis will affect the growths of pharma outsourcing industries in both countries: Comparison of future growth potentials of pharma outsourcing industries between China and India

3.5.1 Future growth potential of pharma outsourcing in China

1. Major short-term growth resistor: Financial crisis

2. Long term growth drivers and resistors

1) Growth drivers

a. Internal drivers

b. External drivers

c. Three outsourcing waves

2) Growth resistors: Challenges Chinese companies are going to face

3.5.2 Future growth potential of pharma outsourcing in India

1. Major short-term growth resistors: Impacts of terror attack and financial crisis

2. Long term growth drivers and resistors

1) Growth drivers

2) Growth resistors

Chapter 4. Which Country Best Fits Your Outsourcing Investment?

Summary

– A Series of Case Studies
4.1 Introduction

4.2 Analysis of real motivations behind different outsourcing strategies played by major pharma/biotech companies in China and India

4.2.1 Different importance of China vs. India to major pharma/biotech companies for long term investment

4.2.2 Different outsourcing strategies played in China and India by major pharma/biotech companies

4.3 Case studies: Examples of drug companies around the world closely collaborating with Chinese and Indian companies

4.3.1 Collaboration between a major Western company and an Indian company

4.3.2 Collaboration between a major Western company and a Chinese company

4.3.3 Collaborations of a major Western company simultaneously with a Chinese company and an Indian company in similar therapeutic areas

4.4 Summaries of more outsourcing collaborations happened in recent two years between Western companies and Chinese or Indian companies

4.5 Where to choose your outsourcing destination: In-depth analyses of pharma outsourcing features of both China and India

Classifications of Top 100 Best Outsourcing Service Providers in China and India

1. List of top pharma companies in China and India

2. List of top biotech companies in China and India

3. List of top CROs in China and India

4. List of top CMOs in China and India

5. List of top API and generic drug makers in China and India

6. List of Chinese and Indian companies with Level 5 service capability

7. List of Chinese and Indian companies with Level 4 service capability

8. List of Chinese and Indian companies with Level 3 service capability

9. List of top CROs in China and India for drug discovery service

10. List of top CROs in China and India for process R&D

11. List of top CROs in China and India for medicinal chemistry research

12. List of top CROs in China and India for preclinical research service

13. List of top CROs in China and India for ADME/Tox study

14. List of top CROs in China and India having non-human primate animal testing facilities

15. List of top CROs in China and India for clinical research service

16. List of top CROs in China and India having central lab service

17. List of top CROs in China and India in genomics and proteomics research

18. List of top Chinese and Indian pharma companies having internal R&D programs

19. List of top Chinese and Indian pharma companies having drug candidates in late development stages

20. List of top Chinese and Indian pharma companies having products marketed globally

21. List of top Chinese and Indian pharma companies having global presences

Appendix

List of Tables

Appendix I. Research Methodology

Appendix II. About JZMed, Inc.
Table 1. Comparison of labor costs in various locations of the world (FTE rates)

Table 2. Market distributions of each service sector in Chinese pharma outsourcing

industry (2007 and 2008)

Table 3. Market development history of Indian pharma outsourcing industry

Table 4. Market distributions of each service sector in Indian pharma outsourcing

industry (2006/2007 – 2007/2008)

Table 5. Market development of global pharma outsourcing industry in recent five years

Table 6. Market development history and future growth forecasts of each service sector

of global pharma outsourcing industry (2006 to 2010)

Table 7. Comparison of higher education between China and India

Table 8. Comparison of technical workforces between China and India in pharma-related

industries

Table 9. Comparison of labor and material costs in pharma outsourcing industries

between China and India

Table 10. Current market sizes and future growth forecasts of Chinese pharmaceutical

market

Table 11. Market development and future growth forecasts of Indian pharmaceutical

markets

Table 12. Drug product development pipelines of Indian pharma and biotech companies

Table 13. Drug product development pipelines of Chinese pharma and biotech companies

Table 14. Head-to-head comparisons of advantages and disadvantages between China

and India in pharma outsourcing-related industries

Table 15. Classification and definition of contract pharmaceutical research and

manufacturing service capability levels

Table 16. List of top 50 best service providers in each country (In alphabetic order of

company names)

Table 17. Comparison of distributions of service providers

Table 18. Comparison of professional service providers in each service sector

Table 19. Comparison of outsourcing service capabilities between Chinese companies

and Indian companies

Table 20. Comparison of internal R&D programs between Chinese companies and Indian

companies

Table 21. Comparison of companies providing service in biopharmaceutical

manufacturing

Table 22. Comparison of global presences of Chinese companies and Indian companies

Table 23. Summary of latest acquisitions of Western companies by Indian companies

Table 24. Summary of comparisons between Chinese companies and Indian companies in

pharma outsourcing-related industries

Table 25. Comparison of WuXi PharmaTech with GVK Biosciences

Table 26. Comparison of Harbin Pharmaceutical Group with Ranbaxy

Table 27. Comparison of Shanghai Sunway Biotech Co. with Intas Biopharmaceuticals

Ltd.

Table 28. Comparison of predicted future outsourcing market developments between

China and India (2009 and 2010)

Table 29. Head-to-head comparison of outsourcing collaborations of Ortho-McNeil

Jassen Pharmaceuticals with a Chinese and an Indian company

Table 30. Summary of outsourcing collaborations happened recently between Western

pharma/biotech companies and Chinese companies

Table 31. Summary of recent outsourcing collaborations between Western

pharma/biotech companies and Indian companies

Table 32. Summary of Western CROs/CMOs establishing presences in China or

forming partnerships with Chinese counterparts

Table 33. Summary of Western CROs/CMOs establishing presences in India or forming

partnerships with Indian counterparts

List of Figures

Figure 1. Development history of Chinese pharma outsourcing market

Figure 2. Current market distributions of each service sector in Chinese pharma

outsourcing industry (2008)

Figure 3. Market development history and future growth forecasts of India�¦s CRAMS

sector

Figure 4. Indian pharma outsourcing market growth history

Figure 5. Market growth history of Indian contract clinical research service sector

Figure 6. Current market distributions of each service sector of Indian pharma

outsourcing industry (2007 �{�n2008)

Figure 7. Comparison between China and India of market shares of each service sector in

each country�¦s total pharma outsourcing markets (2008 data)

Figure 8. Global pharma outsourcing market: Growth history and future development

forecasts

Figure 9. Market distributions of each service sector in global pharma outsourcing

industry

Figure 10. Global contract research service: Market development, distributions and

future growth forecasts of each sector (2006 �{ 2010)

Figure 11. Chinese pharmaceutical market composition of 2008

Figure 12. Development history and future growth forecasts of Indian pharmaceutical

market

Figure 13. Classification and rating of CROs and CMOs

Figure 14. Impacts of financial crisis on Chinese pharma outsourcing industry

Figure 15. Comparison of near future pharma outsourcing market sizes between China

and India (2009 – 2010)

Figure 16. Comparison of future market growth potentials of Chinese and Indian pharma

outsourcing industries (2010 �{�n2015)

Figure 17. Wholly-owned R&D centers established in China by major pharma and

biotech companies

Figure 18. Major pharma and biotech companies having manufacturing facilities in China

Figure 19. Analysis of different investment strategies of major pharma and biotech

companies in China and India

Figure 20. Summary of outsourcing models of major pharma and biotech companies in

China and India

Figure 21. Comparisons of activities of Chinese companies and Indian companies in

overseas markets

Figure 22. Examples of recent investment activities of Western VCs in China

Figure 23. Some typical shortcomings of China and India in pharma outsourcing

	Research Index \| Publishers \| My Account \| Contact Us \| About MindBranch
	Welcome Guest (Login/Register) \| 0 items